Merck Revenue 2010-2024 | MKKGY
Merck annual/quarterly revenue history and growth rate from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Merck revenue for the quarter ending June 30, 2024 was $5.764B, a 0.31% decline year-over-year.
- Merck revenue for the twelve months ending June 30, 2024 was $22.580B, a 2.37% decline year-over-year.
- Merck annual revenue for 2023 was $22.721B, a 3% decline from 2022.
- Merck annual revenue for 2022 was $23.424B, a 0.57% increase from 2021.
- Merck annual revenue for 2021 was $23.292B, a 16.29% increase from 2020.
Merck Annual Revenue
(Millions of US $) |
| 2023 |
$22,721 |
| 2022 |
$23,424 |
| 2021 |
$23,292 |
| 2020 |
$20,029 |
| 2019 |
$18,090 |
| 2018 |
$17,521 |
| 2017 |
$17,324 |
| 2016 |
$16,626 |
| 2015 |
$14,254 |
| 2014 |
$15,288 |
| 2013 |
$14,738 |
| 2012 |
$14,369 |
| 2011 |
$13,799 |
| 2010 |
$12,338 |
| 2009 |
$10,807 |
Merck Quarterly Revenue
(Millions of US $) |
| 2024-06-30 |
$5,764 |
| 2024-03-31 |
$5,559 |
| 2023-12-31 |
$5,628 |
| 2023-09-30 |
$5,630 |
| 2023-06-30 |
$5,781 |
| 2023-03-31 |
$5,682 |
| 2022-12-31 |
$5,817 |
| 2022-09-30 |
$5,848 |
| 2022-06-30 |
$5,925 |
| 2022-03-31 |
$5,833 |
| 2021-12-31 |
$5,977 |
| 2021-09-30 |
$5,864 |
| 2021-06-30 |
$5,868 |
| 2021-03-31 |
$5,583 |
| 2020-12-31 |
$5,474 |
| 2020-09-30 |
$5,199 |
| 2020-06-30 |
$4,535 |
| 2020-03-31 |
$4,821 |
| 2019-12-31 |
$4,864 |
| 2019-09-30 |
$4,508 |
| 2019-06-30 |
$4,464 |
| 2019-03-31 |
$4,255 |
| 2018-12-31 |
$4,196 |
| 2018-09-30 |
$4,359 |
| 2018-06-30 |
$4,429 |
| 2018-03-31 |
$4,537 |
| 2017-12-31 |
$4,549 |
| 2017-09-30 |
$4,380 |
| 2017-06-30 |
$4,280 |
| 2017-03-31 |
$4,115 |
| 2016-12-31 |
$4,128 |
| 2016-09-30 |
$4,156 |
| 2016-06-30 |
$4,298 |
| 2016-03-31 |
$4,043 |
| 2015-12-31 |
$3,795 |
| 2015-09-30 |
$3,489 |
| 2015-06-30 |
$3,560 |
| 2015-03-31 |
$3,464 |
| 2014-12-31 |
$3,398 |
| 2014-09-30 |
$3,896 |
| 2014-06-30 |
$3,827 |
| 2014-03-31 |
$3,654 |
| 2013-12-31 |
$3,729 |
| 2013-09-30 |
$3,645 |
| 2013-06-30 |
$3,769 |
| 2013-03-31 |
$3,581 |
| 2012-12-31 |
$3,646 |
| 2012-09-30 |
$3,555 |
| 2012-06-30 |
$3,520 |
| 2012-03-31 |
$3,274 |
| 2011-12-31 |
$3,311 |
| 2011-09-30 |
$3,585 |
| 2011-06-30 |
$3,677 |
| 2011-03-31 |
$3,505 |
| 2010-12-31 |
$3,707 |
| 2010-09-30 |
$3,145 |
| 2010-06-30 |
$2,695 |
| 2010-03-31 |
$2,791 |
| 2009-12-31 |
$2,983 |
| 2009-09-30 |
$2,778 |
| 2009-06-30 |
$2,590 |
| 2009-03-31 |
$2,456 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$21.306B |
$22.719B |
|
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
|
